Magnitude of clinical benefit of randomized controlled trials supporting US Food and Drug Administration approval of drugs for solid tumours
C. Molto Valiente
◽
E. Amir
◽
A. Ocana Fernandez
◽
A. Templeton
◽
L. del Carpio Huerta
◽
...
M. Borrell Puy
◽
C. Molto Valiente
◽
A. Ocana Fernandez
◽
A. Templeton
◽
B. Seruga
◽
...
2019 ◽
Vol 94
(1)
◽
pp. 74-83
◽
Daniel Shepshelovich
◽
Ariadna Tibau
◽
Hadar Goldvaser
◽
Alberto Ocana
◽
Bostjan Seruga
◽
...
2018 ◽
Vol 36
(15_suppl)
◽
pp. e18717-e18717
Daniel Shepshelovich
◽
Ariadna Tibau
◽
Hadar Goldvaser
◽
Consolacion Molto
◽
Alberto Ocana
◽
...
2018 ◽
Vol 103
◽
pp. 1-9
◽
Emily M. Lord
◽
Isabelle R. Weir
◽
Ludovic Trinquart
2016 ◽
Vol 202
◽
pp. 228-237
◽
Heerajnarain Bulluck
◽
Alex Sirker
◽
Yoon K. Loke
◽
David Garcia-Dorado
◽
Derek J. Hausenloy
2015 ◽
Vol 86
(2)
◽
pp. 274-275
◽
Xiaobo Xie
◽
Yuexing Zhong
◽
Lijun Lin
◽
Qi Li
2017 ◽
Vol 28
(1)
◽
pp. 157-162
◽
J.C. Del Paggio
◽
B. Azariah
◽
R. Sullivan
◽
W.M. Hopman
◽
F.V. James
◽
...
2005 ◽
Vol 20
(10)
◽
pp. 771-793
◽
G. R. Haynes
◽
R. J. Navickis
◽
M. M. Wilkes
2016 ◽
Vol 36
◽
pp. e24-e25
2003 ◽
Vol 20
(10)
◽
pp. 771-793
◽
G. R. Haynes
◽
R. J. Navickis
◽
M. M. Wilkes